Role of [
ISUP grade
PET
PSMA
Prostate cancer
Radiomics
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
06
12
2022
accepted:
01
03
2023
medline:
12
6
2023
pubmed:
19
3
2023
entrez:
18
3
2023
Statut:
ppublish
Résumé
The aim of this study is to investigate the role of [ This retrospective study included 47 PCa patients who underwent [ ISUP grade at biopsy was upgraded in 9/47 patients after prostatectomy, resulting in a bACC = 85.9%, SN = 71.9%, SP = 100%, PPV = 100%, and NPV = 62.5%, while the best-performing radiomic model yielded a bACC = 87.6%, SN = 88.6%, SP = 86.7%, PPV = 94%, and NPV = 82.5%. All radiomic models trained with at least 2 RFs (GLSZM-Zone Entropy and Shape-Least Axis Length) outperformed the control models. Conversely, no significant differences were found for radiomic models trained with 2 or more RFs (Mann-Whitney p > 0.05). These findings support the role of [
Identifiants
pubmed: 36933074
doi: 10.1007/s00259-023-06187-3
pii: 10.1007/s00259-023-06187-3
doi:
Substances chimiques
gallium 68 PSMA-11
0
Gallium Radioisotopes
0
PSMA-11
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2548-2560Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : grant IG 2017 Id.20571
Organisme : Italian Ministry of Health
ID : PE-2016-02361273
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
WCRF. Prostate cancer statistics. 2020. Available from: https://www.wcrf.org/cancer-trends/prostate-cancer-statistics/ . Accessed 1 Jul 2022
Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79:243–62. https://linkinghub.elsevier.com/retrieve/pii/S0302283820307697 .
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563–77. https://doi.org/10.1148/radiol.2015151169 .
Wenzel M, Theissen L, Preisser F, Lauer B, Wittler C, Humke C, et al. Complication rates after TRUS guided transrectal systematic and MRI-targeted prostate biopsies in a high-risk region for antibiotic resistances. Front Surg. 2020;7. https://doi.org/10.3389/fsurg.2020.00007/full .
Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging – reporting and data system: 2015, Version 2. Eur Urol. 2016;69:16–40. https://linkinghub.elsevier.com/retrieve/pii/S0302283815008489 .
Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med. 2020;382:917–28. https://doi.org/10.1056/NEJMoa1910038 .
doi: 10.1056/NEJMoa1910038
pubmed: 32130814
pmcid: 7323919
Ferraro DA, Becker AS, Kranzbühler B, Mebert I, Baltensperger A, Zeimpekis KG, et al. Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study. Eur J Nucl Med Mol Imaging. 2021;48:3315–24. https://doi.org/10.1007/s00259-021-05261-y .
doi: 10.1007/s00259-021-05261-y
pubmed: 33620559
pmcid: 8426229
Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, et al. Diagnostic efficacy of 68 gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol. 2016;195:1436–43. https://doi.org/10.1016/j.juro.2015.12.025 .
doi: 10.1016/j.juro.2015.12.025
pubmed: 26682756
von Eyben FE, Picchio M, von Eyben R, Rhee H, Bauman G. 68Ga-Labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis. Eur Urol Focus. 2018;4:686–93. https://linkinghub.elsevier.com/retrieve/pii/S2405456916301602 .
Donato P, Morton A, Yaxley J, Ranasinghe S, Teloken PE, Kyle S, et al. 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: is 68Ga-PSMA PET/CT guided biopsy the future? Eur J Nucl Med Mol Imaging. 2020;47:1843–51. https://doi.org/10.1007/s00259-019-04620-0 .
Lopci E, Saita A, Lazzeri M, Lughezzani G, Colombo P, Buffi NM, et al. 68 Ga-PSMA positron emission tomography/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study. J Urol. 2018;200:95–103. https://doi.org/10.1016/j.juro.2018.01.079 .
Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395:1208–16. https://linkinghub.elsevier.com/retrieve/pii/S0140673620303147 .
Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, et al. Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. J Urol. 2016;196:1261–7. https://doi.org/10.1016/j.juro.2016.02.3000 .
Ghezzo S, Bezzi C, Presotto L, Mapelli P, Bettinardi V, Savi A, et al. State of the art of radiomic analysis in the clinical management of prostate cancer: a systematic review. Crit Rev Oncol Hematol. 2022;169:103544. https://linkinghub.elsevier.com/retrieve/pii/S1040842821003310 .
Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, et al. Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance. Eur J Nucl Med Mol Imaging. 2021;48:4002–15. https://doi.org/10.1007/s00259-021-05338-8 .
Tunali I, Gillies RJ, Schabath MB. Application of radiomics and artificial intelligence for lung cancer precision medicine. Cold Spring Harb Perspect Med. 2021;11:a039537. https://doi.org/10.1101/cshperspect.a039537 .
Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C, et al. Radiomics in neuro-oncology: basics, workflow, and applications. Methods. 2021;188:112–21. https://linkinghub.elsevier.com/retrieve/pii/S1046202319303172 .
Solari EL, Gafita A, Schachoff S, Bogdanović B, Villagrán Asiares A, Amiel T, et al. The added value of PSMA PET/MR radiomics for prostate cancer staging. Eur J Nucl Med Mol Imaging. 2022;49:527–38. https://doi.org/10.1007/s00259-021-05430-z .
Papp L, Spielvogel CP, Grubmüller B, Grahovac M, Krajnc D, Ecsedi B, et al. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI. Eur J Nucl Med Mol Imaging. 2021;48:1795–805. https://link.springer.com/https://doi.org/10.1007/s00259-020-05140-y .
Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44:1014–24. https://link.springer.com/https://doi.org/10.1007/s00259-017-3670-z .
Montironi R, Mazzucchelli R, van der Kwast T. Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. Virchows Arch. 2003;442:211–7. https://doi.org/10.1007/s00428-002-0741-7 .
Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2016;40:244–52. https://journals.lww.com/00000478-201602000-00010 .
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323–41. https://linkinghub.elsevier.com/retrieve/pii/S0730725X12001816 .
Han C, Ma S, Liu X, Liu Y, Li C, Zhang Y, et al. Radiomics models based on apparent diffusion coefficient maps for the prediction of high-grade prostate cancer at radical prostatectomy: comparison with preoperative biopsy. J Magn Reson Imaging. 2021;54:1892–901. https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/jmri.27565 .
Hatt M, Majdoub M, Vallières M, Tixier F, Le Rest CC, Groheux D, et al. 18 F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi–cancer site patient cohort. J Nucl Med. 2015;56:38–44. https://jnm.snmjournals.org/lookup/doi/https://doi.org/10.2967/jnumed.114.144055 .
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104–7. https://aacrjournals.org/cancerres/article/77/21/e104/662617/Computational-Radiomics-System-to-Decode-the .
Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328–38. https://pubs.rsna.org/doi/https://doi.org/10.1148/radiol.2020191145 .
Orlhac F, Eertink JJ, Cottereau A-S, Zijlstra JM, Thieblemont C, Meignan M, et al. A guide to combat harmonization of imaging biomarkers in multicenter studies. J Nucl Med. 2022;63:172–9. https://jnm.snmjournals.org/lookup/doi/https://doi.org/10.2967/jnumed.121.262464 .
Ding C, Peng H. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol. 2005;03:185–205. https://www.worldscientific.com/doi/abs/https://doi.org/10.1142/S0219720005001004 .
Haibo He, Yang Bai, Garcia EA, Shutao Li. ADASYN: adaptive synthetic sampling approach for imbalanced learning. 2008 IEEE Int Jt Conf Neural Networks (IEEE World Congr Comput Intell. IEEE; 2008. p. 1322–8. https://ieeexplore.ieee.org/document/4633969/ .
Kim J-H. Estimating classification error rate: repeated cross-validation, repeated hold-out and bootstrap. Comput Stat Data Anal. 2009;53:3735–45. https://linkinghub.elsevier.com/retrieve/pii/S0167947309001601 .
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404. https://www.jstor.org/stable/2331986?origin=crossref .
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2022. https://www.R-project.org/ . Accessed 10 Jul 2022.
Gaur S, Harmon S, Rosenblum L, Greer MD, Mehralivand S, Coskun M, et al. Can apparent diffusion coefficient values assist PI-RADS Version 2 DWI Scoring? A correlation study using the PI-RADSv2 and International Society of Urological Pathology Systems. Am J Roentgenol. 2018;211:W33–41. https://www.ajronline.org/doi/https://doi.org/10.2214/AJR.17.18702 .
Sahin M, Kizilay F, Guler E, Sarsik B, Harman M, Kalemci S, et al. Multıparametric prostate magnetic resonance imaging before radical prostatectomy: can it predict histopathology? Urol J. 2020;18:417–21. https://www.ncbi.nlm.nih.gov/pubmed/33037604 .
Kwan TN, Spremo S, Teh AYM, McHarg D, Thangasamy I, Woo HH. Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer. Prostate Int. 2021;9:107–12. https://linkinghub.elsevier.com/retrieve/pii/S2287888220300544 .
Chaddad A, Niazi T, Probst S, Bladou F, Anidjar M, Bahoric B. Predicting Gleason score of prostate cancer patients using radiomic analysis. Front Oncol. 2018;8. https://www.frontiersin.org/article/https://doi.org/10.3389/fonc.2018.00630/full .
McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, et al. Gleason probability maps: a radiomics tool for mapping prostate cancer likelihood in MRI space. Tomography. 2019;5:127–34. https://www.mdpi.com/2379-139X/5/1/127 .
Toivonen J, Montoya Perez I, Movahedi P, Merisaari H, Pesola M, Taimen P, et al. Radiomics and machine learning of multisequence multiparametric prostate MRI: towards improved non-invasive prostate cancer characterization. Penney KL, editor. PLoS One. 2019;14:e0217702. https://dx.plos.org/https://doi.org/10.1371/journal.pone.0217702 .
Hectors SJ, Cherny M, Yadav KK, Beksaç AT, Thulasidass H, Lewis S, et al. Radiomics features measured with multiparametric magnetic resonance imaging predict prostate cancer aggressiveness. J Urol. 2019;202:498–505. https://www.jurology.com/doi/https://doi.org/10.1097/JU.0000000000000272 .
Aksu A, Vural Topuz Ö, Yılmaz G, Çapa Kaya G, Yılmaz B. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Ann Nucl Med. 2022;36:310–8. https://link.springer.com/https://doi.org/10.1007/s12149-021-01705-5 .
Zamboglou C, Carles M, Fechter T, Kiefer S, Reichel K, Fassbender TF, et al. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference. Theranostics. 2019;9:2595–605. https://www.thno.org/v09p2595.htm .
Guglielmo P, Marturano F, Bettinelli A, Gregianin M, Paiusco M, Evangelista L. Additional value of PET radiomic features for the initial staging of prostate cancer: a systematic review from the literature. Cancers (Basel). 2021;13:6026. https://www.mdpi.com/2072-6694/13/23/6026 .
Orlhac F, Soussan M, Maisonobe J-A, Garcia CA, Vanderlinden B, Buvat I. Tumor texture analysis in 18 F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med. 2014;55:414–22. https://jnm.snmjournals.org/lookup/doi/https://doi.org/10.2967/jnumed.113.129858 .
Orlhac F, Nioche C, Klyuzhin I, Rahmim A, Buvat I. Radiomics in PET imaging. PET Clin. 2021;16:597–612. https://linkinghub.elsevier.com/retrieve/pii/S1556859821000468 .
Hatt M, Cheze le Rest C, Turzo A, Roux C, Visvikis D. A Fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans Med Imaging. 2009;28:881–93. https://ieeexplore.ieee.org/document/4749328/ .
MIM. MIM software [Internet]. https://www.mimsoftware.com . Accessed 4 Jul 2022.
Liu C, Gardner SJ, Wen N, Elshaikh MA, Siddiqui F, Movsas B, et al. Automatic segmentation of the prostate on CT images using deep neural networks (DNN). Int J Radiat Oncol. 2019;104:924–32. https://linkinghub.elsevier.com/retrieve/pii/S0360301619303761 .
Andor N, Graham TA, Jansen M, Xia LC, Aktipis CA, Petritsch C, et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat Med. 2016;22:105–13. https://www.nature.com/articles/nm.3984 .
Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, et al. 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48:477–82. https://doi.org/10.1007/s00259-020-04944-2 .
Koerber SA, Utzinger MT, Kratochwil C, Kesch C, Haefner MF, Katayama S, et al. 68 Ga-PSMA-11 PET/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters. J Nucl Med. 2017;58:1943–8. https://doi.org/10.2967/jnumed.117.190314 .
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62. https://www.nature.com/articles/nrclinonc.2017.141 .
Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. https://www.nature.com/articles/ncomms5006 .
Welch ML, McIntosh C, Haibe-Kains B, Milosevic MF, Wee L, Dekker A, et al. Vulnerabilities of radiomic signature development: the need for safeguards. Radiother Oncol. 2019;130:2–9. https://linkinghub.elsevier.com/retrieve/pii/S0167814018335515 .
Hatt M, Krizsan AK, Rahmim A, Bradshaw TJ, Costa PF, Forgacs A, et al. Joint EANM/SNMMI guideline on radiomics in nuclear medicine. Eur J Nucl Med Mol Imaging. 2023;50:352–75. https://doi.org/10.1007/s00259-022-06001-6 .
Feliciani G, Celli M, Ferroni F, Menghi E, Azzali I, Caroli P, et al. Radiomics analysis on [68Ga]Ga-PSMA-11 PET and MRI-ADC for the prediction of prostate cancer ISUP grades: preliminary results of the BIOPSTAGE Trial. Cancers (Basel). 2022;14:1888. https://www.mdpi.com/2072-6694/14/8/1888.